Tracking movement in people with ALS and healthy volunteers
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study continuously measures activity and movement in people with ALS and in control participants. It aims to better understand how muscle disease changes day-to-day function, which may help improve future monitoring or care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are diagnosed with ALS (or considered very likely to have ALS) based on standard neurology criteria.
- You are over 18 years old.
- You can sign informed consent (agree to take part after understanding what it involves).
- If you take riluzole for ALS, your dose has been steady for at least 1 month and you would keep it the same during the study.
- You should not have major memory/thinking problems or communication issues that make it hard to do the study tasks and collect the data.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a wearable device to track movement patterns in people with ALS. It aims to better understand how the disease affects movement over time, which may help improve care.
This study follows people with ALS and healthy volunteers to measure how specific body fluids, symptoms, and at-home tracking change over time. It may help researchers find early signs of disease changes and better ways to measure treatment effects.
This study follows people living with amyotrophic lateral sclerosis (ALS) over time. It may help researchers better understand ALS and track changes that could guide future treatments.
This trial uses MRI scans to look for “imaging biomarkers” (scan patterns that may help track ALS). It may help researchers better understand disease changes over time and how ALS progresses.
This study uses a comprehensive analysis platform to better understand ALS (and related conditions) and help find ways to “remedy and eliminate” it. If you have ALS or are a healthy control who can safely complete questionnaires and possibly an MRI, you may be able to contribute data that researchers use to improve care.
This study looks at how people with ALS walk while doing another task (like talking or counting). It aims to understand how the disease affects movement when you're focused on something else, which could help with future care.
Hear when a new Amyotrophic Lateral Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.